Emory University investigators will receive a total of $955,000 in funding for new research projects from the Morningside Center for Innovative and Affordable Medicine, an interdisciplinary unit within Emory's Woodruff Health Sciences Center.
The six awards given during the inaugural grant cycle include five team projects led by researchers from Winship Cancer Institute of Emory University. Though the initial focus of the Morningside Center has been on cancer, proposals in all disease areas were encouraged.
The Morningside Center was created to promote research, education, and advocacy for effective and affordable medical treatments. The inaugural calls for Research Award proposals focused on strategic areas: (1) preclinical work critical to supporting clinical trials, (2) biomarker development for repurposed drug studies, and (3) clinical trials ready for implementation.
This cycle's Morningside Center Research Awards recipients are:
- Levodopa Treatment for Diabetic Retinopathy
Project Leader: Andrew Hendrick, MD
- Repurposing CD26/DPP4 inhibitors for immunotherapy of cancer
Project Leader: Gregory B. Lesinski, PhD, MPH
- Targeting patients with breast adipose tissue inflammation for statin therapy to prevent breast cancer recurrence
Project Leader: Lauren E. McCullough, PhD, MSPH
- Repurposing Verteporfin for Treatment of Pediatric High-grade Gliomas
Project Leader: Renee Read, PhD
- Repurposing Statin Drugs to Enhance Immunotherapy in Head and Neck Cancer
Project Leader: Nicole Schmitt, MD, FACS
- Indole-3-Carbinol Supplement for Prevention of Serious Acute Graft Versus Host Disease
Project Leader: Edmund K. Waller, MD, PhD